Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27705439 | 1.00 | LMNA (0.40) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL9094485 | 1.00 | LMNA (0.40) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Glycerin SCHEMBL27636932 | 0.94 | LMNA (0.36) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL23856035 | 0.87 | AKR1B1 (0.33) | LMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL23856034 | 0.87 | AKR1B1 (0.33) | LMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL2185848 | 0.87 | AKR1B1 (0.33) | LMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL215647 | 0.87 | AKR1B1 (0.33) | LMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL17843661 | 0.80 | — | — | |
| SCHEMBL27636929 | 0.80 | — | — | |
| SCHEMBL5371396 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119587702-A | Pharmaceutical composition capable of improving bioavailability of oral statin drugs and application thereof | 强生化学制药厂股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-105238721-A | Pesticide degradation bacterium and application thereof | UNIV SICHUAN | 2016-01-13 | — | — | CN | claimed |
| CN-104232503-A | Bacillus shacheensis and application thereof | UNIV SICHUAN | 2014-12-24 | — | — | CN | claimed |
| EP-4692129-A1 | CAROB POLYSACCHARIDE CAPABLE OF SUPPRESSING COUGH, REDUCING PHLEGM AND ENHANCING IMMUNITY, PREPARATION METHOD THEREFOR, AND USE THEREOF | Nagayoshi Pharmaceutical Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024203624-A1 | CAROB POLYSACCHARIDE CAPABLE OF SUPPRESSING COUGH, REDUCING PHLEGM AND ENHANCING IMMUNITY, PREPARATION METHOD THEREFOR, AND USE THEREOF | ナガヨシ製薬株式会社 | 2024-10-03 | — | — | WO | disclosed |
| CN-118324940-A | Carob polysaccharide, nanoparticle, and preparation method and application thereof | 永吉制药株式会社 | 2024-07-12 | — | — | CN | disclosed |
| CN-118324939-A | Carob polysaccharide and nanoparticle with effect of improving colonic inflammation and application thereof | 永吉制药株式会社 | 2024-07-12 | — | — | CN | disclosed |
| US-20240172770-A1 | COFFEE MELANOIDIN NANOPARTICLES AND NANOFIBERS | KAFFE BUENO APS. (DK) | 2024-05-30 | — | — | US | disclosed |
| EP-4358728-A1 | COFFEE MELANOIDIN NANOPARTICLES AND NANOFIBERS | Kaffe Bueno ApS (DK) | 2024-05-01 | — | — | EP | disclosed |
| WO-2022268898-A1 | COFFEE MELANOIDIN NANOPARTICLES AND NANOFIBERS | KAFFE BUENO APS. (DK) | 2022-12-29 | — | — | WO | disclosed |
| EP-4108094-A1 | COFFEE MELANOIDIN NANOPARTICLES AND NANOFIBERS | Kaffee Bueno ApS (DK) | 2022-12-28 | — | — | EP | disclosed |
| CN-1150903-C | Peritoneal dialysis solutions containing improved icodextrin | ���Ͽع�����˾ | 2004-05-26 | — | — | CN | disclosed |
| CN-1292639-A | Method for controlling traget microorganism | TOYOTA MOTOR CO LTD (JP) | 2001-04-25 | — | — | CN | disclosed |
| EP-1060668-A1 | METHOD FOR CONTROLLING TARGET MICROORGANISM | Toyota Jidosha Kabushiki Kaisha (JP) | 2000-12-20 | — | — | EP | disclosed |
| US-5753252-A | TAMPONS; COMPRISING AN ADSORBENT MATERIAL AND AN ENTEROTOXIN INHIBITOR SELECTED FROM MONOESTER OF POLYHYDRIC ALCOHOL WITH ATLEAST ONE HYDROXY GROUP AND DIESTER OF POLYHYDRIC ALCOHOL WITH ATLEAST ONE ALCOHOL | MCNEIL-PPC, INC. (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0483812-B1 | Prevention of toxin production using absorbent products | MCNEIL PPC INC (US) | 1996-08-21 | — | — | EP | disclosed |
| US-5389374-A | Exposing absorbent product to enterotoxin producing bacteria, where the absorber contains an alcohol group containing ester or diester | MCNEIL-PPC, INC. (US) | 1995-02-14 | — | — | US | disclosed |
| EP-0483812-A1 | Prevention of toxin production using absorbent products | McNEIL-PPC, INC. (US) | 1992-05-06 | — | — | EP | disclosed |
| US-4435433-A | WITH AN ALKYLATED REDUCING SUGAR | ARMOUR FOOD COMPANY (US) | 1984-03-06 | — | — | US | disclosed |
| US-4102859-A | PHOSPHOROUS ACID ESTERS WITH OXETANE COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-07-25 | — | — | US | disclosed |